In a recent lawsuit that further escalates the global legal dispute between Abbott Laboratories and Dexcom, a Delaware federal jury gave a mixed verdict. The jury found that Dexcom, a medical device company, infringed on a glucose monitor patent claimed by an Abbott Laboratories unit. Interestingly, the jury concluded that Dexcom owes no damages for this infringement.
However, the jury was unable to reach a consensus on another claim made by Abbott Laboratories. They cleared Dexcom of accusations related to infringement on two more of Abbott’s patents.
This legal dispute underscores the tense competition within the medical device industry, specifically concerning technologies related to glucose monitoring. Both Abbott Laboratories and Dexcom are key players in this field, making the outcomes of these types of suits critical to the evolution of the industry.
This case forms only part of the multi-faceted, international legal conflict currently unfolding between the two companies. For more detailed coverage of the ongoing litigation and its implications, visit Law360.